Results 191 to 200 of about 477,025 (329)

Duplex Sonography and Doppler Evaluation of Renal Cell Carcinoma With Inferior Vena Cava Involvement [PDF]

, 1989
Carol A. Krebs, Vishan L. Giyanani, Linda A. Nall   +2 more
openalex   +1 more source

Chromophobe renal cell carcinoma with sarcomatoid change: A case report. [PDF]

Oncol Lett
Ahn AR, Noh SJ, Jeong YB, Kim KM.
europepmc   +1 more source

Engineering antibodies with cancer‐associated binding sites

BMEMat, EarlyView.
This review describes antibodies that perform direct/indirect roles in cancer treatment by binding to effective targets and discusses how antibodies kill tumors and modulate tumor microenvironment through these targets. The classification of expression systems for antibody production is summarized to guide appropriate selection based on different ...
Yinqi Tian, Yumeng Pan, Yingchun Zhang, Fangling Wang, Zejun Wang   +4 more
wiley   +1 more source

Pembrolizumab-Induced Hypophysitis in the Setting of Renal Cell Carcinoma. [PDF]

Cureus
Ogbodu K, Sharda M, Vanani NB, Jha P.
europepmc   +1 more source

Unveiling the complexity of cellular senescence in cancers: From mechanism to therapeutic opportunities

BMEMat, EarlyView.
This review highlights the complex roles of cellular senescence in cancer progression and suppression, discusses the mechanisms and regulatory pathways involved, and evaluates the efficacy of the “One‐Two punch” sequential treatment approach while addressing emerging challenges in this novel therapeutic strategy.
Qiuming Pan, Ye Zhu, Zhi Ye, Huayang Zhang, Junxi Wang, Guozhong Yi, Zhiyong Li, Rongyang Xu, Luyao Wang, Zhenzhen Wu, Songtao Qi, Guanglong Huang, Shanqiang Qu   +12 more
wiley   +1 more source

The accessory renal arteries: A systematic review with meta‐analysis

Clinical Anatomy, EarlyView.
Abstract The accessory renal arteries (ARAs) are a well‐described variant of the renal vasculature with clinical implications for radiologists, surgeons, and clinicians. The aim of the present systematic review with meta‐analysis was to estimate the pooled prevalence of ARAs, including their variant number, origin, and termination, and to highlight ...
George Triantafyllou, Ioannis Paschopoulos, Andrzej Węgiel, Łukasz Olewnik, George Tsakotos, Nicol Zielinska, Maria Piagkou   +6 more
wiley   +1 more source

Renal cell carcinoma in a cow.

, 1986
Shigeru Sato, Toshiyuki Suzuki, Ryoichi Yokoyama, Kan-ichi OHSHIMA, Kosuke Okada   +4 more
openalex   +2 more sources

Papillary Renal Cell Carcinoma With Widespread Metastases in an Arabian Mare. [PDF]

Vet Med Sci
Azari O, Ghamsari SM, Roustaei A, Golchin D, Baharloo F, Javaheri M, Valizadeh N.   +6 more
europepmc   +1 more source

A phase II basket trial of dual anti‐CTLA‐4 and anti‐PD‐1 blockade in rare tumors (DART) SWOG S1609: durable responses and delayed pseudoprogression in small cell carcinoma of the ovary, hypercalcemic type cohort

Cancer Communications, EarlyView.
Abstract Background The combined use of anti‐programmed cell death protein 1 (PD‐1)/anti‐cytotoxic T‐lymphocyte associated protein 4 (CTLA‐4) checkpoint inhibitors has been effective in various cancer types. The Southwest Oncology Group (SWOG) Dual Anti‐CTLA‐4 and Anti‐PD‐1 Blockade in Rare Tumors (DART) S1609 study investigated ipilimumab and ...
Young Kwang Chae, Megan Othus, Sandip Pravin Patel, Raid Aljumaily, Khine Z. Win, Tanya Pejovic, Sajeve S. Thomas, William R. Robinson III, Hye Sung Kim, Liam Il‐Young Chung, Christine M. McLeod, Helen X. Chen, Elad Sharon, Howard Streicher, Christopher W. Ryan, Charles D. Blanke, Razelle Kurzrock   +16 more
wiley   +1 more source

CHEMOTHERAPY OF RENAL CELL CARCINOMA

, 1984
Yoshiaki Satomi, Yutaka Senga, Momokuni Fukuda, Tsuneo Kawai   +3 more
openalex   +2 more sources